Back to search
FDAFDA · Food and drugs·Recall number D-1377-2012

Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1.

Published June 20, 2012 · Recall initiated: May 1, 2012

Summary

FDA records drug Class II recall D-1377-2012, published June 20, 2012 and initiated May 1, 2012. Recalling firm: Ben Venue Laboratories Inc; Status: Terminated; Reported quantity: 6,515 packs; Lot: Lot # 2006500, Exp 08/31/12. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ben Venue Laboratories Inc
Distributor
Nationwide and Puerto Rico.
Lot
Lot # 2006500, Exp 08/31/12
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1. recalled?

Yes. FDA published recall D-1377-2012 on June 20, 2012. Reported hazard: Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter